COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 2703: Articles 27021-27030  | Next

Visualizing the COVID-19 pandemic in Bangladesh using coxcombs: A tribute to Florence Nightingale
Rahaman Khan, H., Howlader, T.
10.1101/2020.05.23.20110866 — Posted: 2020-05-24
A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection
van de Veerdonk, F. L., Janssen, N. A. F., Grondman, I., de Nooijer, A. H., Koeken, V. A. C. M., Matzaraki, V., Boahen, C. K., Kumar, V., Kox, M., Koenen, H. J. P. M., Smeets, R. L., Joosten, I., Brüggemann, R. J. M., Kouijzer, I. J. E., van der Hoeven, H. G., Schouten, J. A., Frenzel, T., Reijers, M., Hoefsloot, W., Dofferhoff, A. S. M., Kerckhoffs, A. P. M., Blaauw, M. J. T., Veerman, K., Maas, C., Schoneveld, A. H., Hoefer, I. E., Derde, L. P. G., Willems, L., Toonen, E., van Deuren, M., van der Meer, J. W. M., van Crevel, R., Giamarellos-Bourboulis, E. J., Joosten, L. A. B., van den Heuvel, M. M., Hoogerwerf, J., de Mast, Q., Pickkers, P., Netea, M. G.
10.1101/2020.05.23.20110916 — Posted: 2020-05-24 Discussion: Onsite
Modelling the impact of Plasma Therapy and Immunotherapy for Recovery of COVID-19 Infected Individuals
Shah, N. H., Suthar, A. H., Jayswal, E. N., Shukla, N., Shukla, J.
10.1101/2020.05.23.20110973 — Posted: 2020-05-24
SARS-CoV-2 lethality decreased over time in two Italian Provinces
Flacco, M. E., Acuti Martellucci, C., Bravi, F., Parruti, G., Mascitelli, A., Mantovani, L., Manzoli, L.
10.1101/2020.05.23.20110882 — Posted: 2020-05-24 Discussion: Onsite
Ethnics and economics in COVID-19: Meta-regression of data from countries in the New York metropolitan area
Takagi, H., Kuno, T., Yokoyama, Y., Ueyama, H., Matsushiro, T., Hari, Y., Ando, T.
10.1101/2020.05.22.20110791 — Posted: 2020-05-24
Importations of COVID-19 into African countries and risk of onward spread
Sun, H., Dickens, B. L., Cook, A. R., Clapham, H. E.
10.1101/2020.05.22.20110304 — Posted: 2020-05-24
Anti-SARS-CoV-2 IgG antibodies are associated with reduced viral load
Bryan, A., Fink, S. L., Gattuso, M. A., Pepper, G., Chaudhary, A., Wener, M., Morishima, C., Jerome, K., Mathias, P. C., Greninger, A. L.
10.1101/2020.05.22.20110551 — Posted: 2020-05-24
Conditions for a second wave of COVID-19 due to interactions between disease dynamics and social processes
Pedro, S. A., Ndjomatchoua, F. T., Jentsch, P., Tcheunche, J. M., Anand, M., Bauch, C. T.
10.1101/2020.05.22.20110502 — Posted: 2020-05-24
Rate Estimation and Identification of COVID-19 Infections: Towards Rational Policy Making During Early and Late Stages of Epidemics
Beigel, R., Kasif, S.
10.1101/2020.05.22.20110585 — Posted: 2020-05-24
Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people
Miles, A., Webb, T. E., Mcloughlin, B., Mannan, I., Rather, A., Knopp, P., Davis, D.
10.1101/2020.05.22.20110486 — Posted: 2020-05-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).